KRAS and non-small cell lung carcinoma: Acquired KRAS alterations, RTK/RAS/MAPK/PI3K alterations, and acquired gene fusions appeared to be more common in CRC than in NSCLC in this cohort suggesting possible underlying differences in genomic instability or DNA damage-response mechanisms between CRC and NSCLC.